Tianjin Pharmaceutical announced that it has received the European Pharmacopeia applicability certification for betamethasone dipropionate APIs issued by the European Medicines Quality Administration.
津药药业：二丙酸倍他米松原料药获得CEP证书
Tianjin Pharmaceutical: Betamethasone dipropionate API obtained CEP certificate
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.